Senegal is now the fifth West African country to be affected by the deadly virus, along with Guinea, Sierra Leone, Liberia, and Nigeria.
A university student infected by Ebola in Guinea traveled to Senegal seeking treatment in the country’s capital Dakar this week, according to Health Minister Awa Marie Coll Seck. The student said he had had contact with infected patients in Guinea and was immediately quarantined.
Senegal shares a border with Guinea, where the outbreak began last year. In March, Senegal closed the border to prevent the spread of the outbreak, which has killed more than 1,500 people so far.
Starting Tuesday, Sept. 2, researchers will test 20 healthy adult volunteers with the vaccine to verify its safety and effectiveness. The vaccine was developed by the National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline.
NIAID’s director, Dr. Anthony Fauci, said this is the first time this vaccine will be tested. The trial was sped up in response to the outbreak ravaging West Africa.
WHO said the disease could end up infecting 20,000 people.
As of Aug. 28, at least 3,000 people have been infected by Ebola and 1,552 people have died. More than 40% of the total number of cases have occurred within the past 21 days, according to WHO.